Physician Assistant, Medical · Milwaukee, WI
NPI
1316508617
Since 2019
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3237 S 16th St
Milwaukee, WI, 53215
Phone (414) 769-4040
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
336 services
Medicare patients, 2024
175
Average age 65
Drug cost, 2024
$8.3M
7,656 prescriptions
Company payments, 2025
$6,768
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna K Cluskey was code 99213 (office e&m - established), 115 times for 88 patients. In total Anna K Cluskey billed 336 services in 14 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 115 | 88 | $37.77 | $4,343 |
| 99214 Office E&M - Established | Facility | 115 | 87 | $53.27 | $6,126 |
| 36514 Hematology | Facility | 60 | 22 | $57.79 | $3,468 |
By year: 2022 $1.3M for 20,180 services; 2023 $1.1M for 19,743 services; 2024 $16K for 336 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna K Cluskey prescribed most often to Medicare patients was Gabapentin, with 508 prescriptions and refills. In total Anna K Cluskey wrote 7,656 Medicare prescriptions that cost $8.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 508 | 914 | 138 | $11K |
| Baclofen Generic | 507 | 955 | 131 | $14K |
| Dalfampridine Er Dalfampridine | 396 | 528 | 68 | $115K |
| Tizanidine Hcl Generic | 274 | 525 | 74 | $7,722 |
| Teriflunomide Generic | 262 | 304 | 42 | $219K |
| Modafinil Generic | 250 | 307 | 54 | $25K |
| Kesimpta Pen Ofatumumab | 195 | 197 | 21 | $1.8M |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 193 | 197 | 40 | $6,163 |
| Duloxetine Hcl Generic | 166 | 306 | 32 | $6,792 |
| Pregabalin Generic | 162 | 232 | 39 | $3,989 |
| Amantadine Amantadine Hcl | 146 | 309 | 40 | $8,619 |
| Aubagio Teriflunomide | 144 | 148 | 20 | $1.4M |
| Topiramate Generic | 138 | 300 | 35 | $2,667 |
| Levetiracetam Generic | 135 | 263 | 30 | $5,879 |
| Zolpidem Tartrate Generic | 131 | 192 | 29 | $1,374 |
Brand drugs: - claims; generic drugs: 6,418 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna K Cluskey $6,768 ($6,768 in general payments such as food, travel and fees) from 22 companies. The largest payer was Genzyme Corporation with $1,558.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 8 | $1,558 |
| Janssen Biotech, Inc. JNJ | 2 | $1,375 |
| EMD Serono, Inc. MRK.DE | 21 | $951 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $499 |
| Biogen, Inc. BIIB | 14 | $490 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $307 |
| TG Therapeutics, Inc. TGTX | 5 | $298 |
| UCB, Inc. UCB.BR | 3 | $234 |
| Amgen Inc. AMGN | 6 | $199 |
| Abbvie Inc. ABBV | 12 | $182 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.